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Abstract 24	
Purpose: CMV retinitis remains a leading cause of blindness in countries with a 25	
high burden of AIDS. Although dilated fundus examinations are recommended for 26	
those with CD4 counts below 100 cells/µL, in practice only those with poor vision 27	
and/or symptoms are routinely referred for screening. Therefore, the predictive 28	
value of this common practice should be assessed.  29	
Methods: This is a prospective cross-sectional study. Patients with known HIV 30	
and a CD4 count of less than 100 cells/µL attending an HIV clinic in Chiang Mai, 31	
Thailand completed a standardized questionnaire about visual symptoms and 32	
underwent visual acuity testing and dilated fundus examination. Participants 33	
without CMV retinitis were invited for repeated examinations every 3 months until 34	
their CD4 count exceeded 100 cells/µL. Patient-level statistical analyses were 35	
conducted to calculate diagnostic test characteristics, with bootstrapping to 36	
account for correlated data. 37	
Results: HIV patients with CMV retinitis were more likely to complain of visual 38	
symptoms (p = 0.01) compared to those without CMV retinitis, including scotoma (p 39	
= 0.0002), itchy or watery eyes (p < 0.0001), and eye pain (p = 0.003); they were 40	
also more likely to have visual acuity worse than CF (p = 0.0003). However, the 41	
absence of eye symptoms and the absence of poor vision did not strongly affect 42	
the probability that a patient did not have disease (negative likelihood ratio 0.56 43	
and 0.76, respectively).  44	
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Conclusions: Ocular symptoms and poor visual acuity were poor diagnostic 45	
indicators for the presence of CMV retinitis. Systemic screening for HIV patients 46	
with CD4 count below 100 cells/µl should be carried out to catch the disease at its 47	
early stage to avoid blindness. 48	
 49	
 50	
  51	
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Introduction 52	
Cytomegalovirus (CMV) retinitis is an opportunistic infection that is a leading 53	
cause of blindness in developing countries with a high burden of AIDS (1,2). 54	
Experts generally recommend asymptomatic screening with indirect 55	
ophthalmoscopy for HIV patients with CD4 counts less than 100 cells/µl in order to 56	
diagnose the disease at an early stage before any visual disability has occurred. 57	
However, in resource-limited settings, the reality is that only patients with visual 58	
symptoms or poor visual acuity are referred for a screening examination. We were 59	
interested in assessing this common practice specifically for at-risk patients in a 60	
primary care setting in Asia. The predictive value of symptoms and vision in such a 61	
population has not been well characterized, even though the vast majority of CMV 62	
retinitis occurs in Asia (3), and even though primary care HIV providers make 63	
clinical decisions about whether to screen for CMV retinitis (1). In this prospective 64	
cross-sectional study, we assessed the relationship between self-reported ocular 65	
symptoms, visual acuity, and an eventual diagnosis of CMV retinitis to determine 66	
whether HIV providers could increase the yield of eye screening examinations by 67	
asking about visual symptoms and testing for vision.  68	
 69	
Materials and Methods 70	
This was a prospective cross-sectional study conducted with approval from 71	
the Committee on Human Research at the University of California, San Francisco 72	
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and the Institutional Review Board of Nakornping Hospital, Chiang Mai, Thailand. It 73	
was performed in adherence with the tenets of the Declaration of Helsinki.  74	
Details of the study population and enrollment process have been described 75	
elsewhere (4). Briefly, from June 18, 2010 through June 15, 2012, patients with a 76	
CD4 cell count of less than 100 cells/µL who presented to the HIV clinic at 77	
Nakornping Hospital in Chiang Mai, Thailand were offered enrollment in the study. 78	
Patients who were pregnant, younger than 18 years, or had a diagnosis of CMV 79	
retinitis were excluded. After written informed consent, participants were asked if 80	
they had any ocular symptoms using a standardized questionnaire administered by 81	
a designated nurse. Visual acuity was then assessed with spectacles and pinhole, 82	
followed by a dilated fundus examination by a fellowship-trained retina specialist 83	
(CJ) to determine the presence or absence of CMV retinitis. Study participants 84	
without CMV retinitis were offered repeated screening every 3 months until their 85	
CD4 cell count increased to 100/µL or greater; the same questionnaire and 86	
examinations were conducted at each study visit. 87	
We performed patient-level statistical analyses. Diagnostic test 88	
characteristics, i.e. sensitivity, specificity, positive and negative predictive values, 89	
positive and negative likelihood ratios, were calculated considering a positive test 90	
to be symptoms in either eye or visual acuity of Counting Fingers (CF) in the 91	
worse-seeing eye, and patients were considered to have CMV retinitis if it was 92	
detected in either eye. Study participants were censored after the first eye was 93	
diagnosed with CMV retinitis. Bootstrapped 95% confidence intervals (10000 94	
repetitions, re-sampled at the patient level) were calculated to account for 95	
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correlated data (i.e., multiple visits by the same participant). All statistical analyses 96	
were performed using Stata/SE 14.0 (StataCorp LP, College Station, Texas).  97	
 98	
Results 99	
Of 258 patients with CD4 counts under 100 cells/µL seen in the HIV clinic 100	
during the study period, 103 were enrolled, including 23 who had 1 subsequent 101	
ophthalmologic examination and 5 who had 2 subsequent examinations. Mean age 102	
was 37.5 years and 61.2% were male. Mean enrollment CD4 count was 29.5 103	
cells/µL. Sixteen patients were diagnosed with CMV retinitis in either eye at some 104	
point during the study.  105	
Among the 16 person-visits where CMV retinitis was diagnosed in either 106	
eye, nine or 56.3% reported a history of ocular symptoms and four or 25.0% had 107	
visual acuities of worse than CF in the worse-seeing eye (Table 1). Among the 120 108	
person-visits where CMV retinitis was not detected in either eye, the corresponding 109	
numbers were 26 (21.7%) and 2 (1.7%, Table 1). Symptoms were more often 110	
reported at patient-visits in which CMV retinitis was diagnosed compared with 111	
those visits where CMV retinitis was not diagnosed (p = 0.01); symptoms that were 112	
significantly more common among patients with CMV retinitis included scotoma (p 113	
= 0.0002), itchy or watery eyes (p < 0.0001), and eye pain (p = 0.003). Reduced 114	
visual acuity was also more frequent when CMV retinitis was eventually diagnosed; 115	
patients diagnosed with CMV retinitis were more likely to have visual acuity worse 116	
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than CF (p = 0.0003) and less likely to have visual acuity better than 20/40 117	
compared to other patients (p = 0.02, Table 1). 118	
 119	
 120	
Table 1. Association of cytomegalovirus (CMV) retinitis with ocular symptoms and visual acuity 121	
 122	
 N (%) or Mean (95% CI)  
Characteristic No CMV retinitis  
N=120 person-visitsa  
CMV retinitis           
N=16 person-visits 
P-valueb 
Symptoms    
    Any symptom 26 (21.7%) 9 (56.3%) 0.01 
    Blurry vision 21 (17.5%) 3 (18.8%) 0.93 
    Flashes/floaters 9 (7.5%) 2 (12.5%) 0.48 
    Scotoma 1 (0.83%) 2 (12.5%) 0.0002 
Itchy or watery eyes 1 (0.83%) 2 (12.5%) <0.0001 
Eye pain 1 (0.83%) 1 (6.25%) 0.003 
Vision    
Better than 20/40 106 (88.3%) 10 (62.5%) 0.02 
20/40 to Counting Fingers 10 (8.3%) 2 (12.5%) 0.56 
Worse than Counting Fingers 2 (1.7%) 4 (25.0%) 0.0003 
a Includes (1) the baseline examinations of 87 participants who were never diagnosed with CMV 123	
retinitis in either eye and 3 participants eventually diagnosed with CMV retinitis at the 3-month 124	
examination, (2) the 3-month examinations of 25 participants who were never diagnosed with CMV 125	
retinitis, and (3) the 6-month examinations of 5 participants who were never diagnosed with CMV 126	
retinitis in either eye.  127	
b Logistic regression performed with bootstrapped 95% confidence intervals to account for multiple 128	
visits from the same patient (10,000 replications, re-sampled at patient level) 129	
 130	
 131	
Relative to an ophthalmologist examination, the presence of any ocular 132	
symptom had a sensitivity of 56.3% (32.0 – 80.5%) and specificity of 78.0% (69.7 – 133	
86.3%) for the diagnosis of CMV retinitis. In comparison, the presence of visual 134	
acuity worse than CF was 25.0% (3.47– 46.5%) sensitive and 98.3% (95.9 – 135	
100%) specific for diagnosing CMV retinitis (Table 2). In this study, the prevalence 136	
of CMV retinitis among the screened population was 15.5%. At this prevalence, the 137	
positive predictive value of ocular symptoms and visual acuity worse than CF were 138	
25.7% (11.2 – 40.3%) and 66.7% (29.0 – 100%), respectively, and the 139	
corresponding negative predictive values were 92.9% (87.9 – 98.0%) and 90.6% 140	
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(85.6 – 95.6%, Table 2). When diagnostic accuracy was expressed as likelihood 141	
ratios, the probability of having CMV retinitis was greatly increased by the 142	
presence of visual acuity worse than CF (positive likelihood ratio 14.8, 95%CI 2.93 143	
– 74.2), whereas eye symptoms increased the probability of CMV retinitis by a 144	
smaller degree (positive likelihood ratio 2.6, 95%CI 1.5 – 4.4). The absence of 145	
symptoms and the absence of poor vision were much less useful for ruling out 146	
disease, with negative likelihood ratios of 0.56 and 0.76, respectively. 147	
 148	
Table 2. Diagnostic test characteristics of ocular symptoms and visual acuity for the prediction of 149	
CMV retinitis. 150	
 151	
 Diagnostic test characteristic (95% CI)a 
 Presence of any type of ocular 
symptom in either eye 
Vision worse than Counting 
Fingers in the worse-seeing eye 
Sensitivity 56.3% (32.0 – 80.5%) 25.0% (3.47– 46.5%) 
Specificity 78.0% (69.7 – 86.3%) 98.3% (95.9 – 100%) 
Positive Predictive Value 25.7% (11.2 – 40.3%) 66.7% (29.0 – 100%) 
Negative Predictive Value 92.9% (87.9 – 98.0%) 90.6% (85.6 – 95.6%) 
Positive likelihood ratio  2.6 (1.5 – 4.4) 14.8 (2.93 – 74.2) 
Negative likelihood ratio 0.56 (0.32 – 0.99) 0.76 (0.57 – 1.01) 
ROC area 0.67 (0.54 – 0.80) 0.62 (0.51 – 0.73) 
CI: confidence interval; CMV: cytomegalovirus; ROC: receiver operating characteristic 152	
a Bootstrapped 95% confidence intervals (CIs) constructed (10,000 replications, sampled at the 153	
patient level) to account for multiple visits from the same individual. 154	
 155	
Discussion 156	
In this study population with a CD4 count below 100 cells/µL presenting to a 157	
primary care HIV clinic, the presence of ocular symptoms and reduced visual 158	
acuity considerably increased the likelihood of having CMV retinitis, but had low 159	
positive predictive value at the relatively low prevalence of retinitis found in this 160	
population. The absence of eye symptoms and the absence of poor vision were 161	
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better predictors for not having CMV retinitis. This was likely due to the low 162	
prevalence of disease, since the presence of eye symptoms and poor vision did 163	
not greatly change the likelihood that an individual had CMV retinitis.  164	
Although several prior studies have assessed the relationship between 165	
visual symptoms, visual acuity, and CMV retinitis, few have been done in Asia (5). 166	
The most relevant prior studies are from India and Vietnam, and enrolled 167	
prospective series of HIV patients for CMV retinitis screening (6,7). The present 168	
study differs from these two studies in that unlike the Indian study, we included 169	
only those HIV patients with a CD4 count less than 100 cells/µL, and unlike the 170	
Vietnamese study, we performed screening at a primary care HIV clinic instead of 171	
an eye clinic. Our findings were generally consistent with these other two studies, 172	
which also found a poor positive predictive value (18-40%) and a higher negative 173	
predictive value (40-95%).  174	
Some previous studies have assessed the relationship between milder 175	
forms of visual impairment and CMV retinitis (7,5). However, we thought it was 176	
unlikely that providers in a busy HIV clinic would routinely test for Snellen visual 177	
acuity. We reasoned that testing for Counting Fingers vision was a quick test that 178	
could easily be incorporated into an HIV provider’s clinic visit, and hence could be 179	
a valuable diagnostic test. We found that this test for low vision was a poor 180	
predictor of CMV retinitis. Its negative predictive value was better; that is, those 181	
with vision of Counting Fingers or better were unlikely to have CMV retinitis. 182	
However, the high negative predictive value was most likely due to the overall low 183	
prevalence of CMV retinitis in the population, since poor vision had a negative 184	
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likelihood ratio of 0.76, which suggests that having good vision did not strongly 185	
change the probability that a person did not have CMV retinitis.   186	
Our study also found that CMV retinitis patients were more likely to complain 187	
of itchy or watery eyes compared to HIV patients without CMV retinitis. 188	
Keratoconjunctivitis sicca is one of the most common ophthalmic manifestations of 189	
HIV/AIDS, and it was thought to be related to an autoimmune phenomena such as 190	
Sjogren-like syndrome that caused abnormal lymphocytic infiltration of the lacrimal 191	
gland (8). The prevalence of dry eye syndrome among HIV patients, however, has 192	
significantly decreased over the years possibly as a result of HAART (9). The 193	
results of our study therefore suggest that while scotoma, floater and flashes are 194	
common symptoms to be associated with retinal detachment in the setting of CMV 195	
retinitis, dry eyes should be another important symptom to elicit during history-196	
taking that is associated with worse immune function and eye disease among HIV 197	
patients.  198	
We specifically designed the present study to mimic the clinical decision-199	
making that an HIV provider faces when deciding whether to perform CMV retinitis 200	
screening. We reduced selection bias by conducting the study at a primary care 201	
HIV clinic instead of an ophthalmology clinic and by enrolling only those patients 202	
with CD4 counts below 100 cells/ µL, who are at the greatest risk. We performed 203	
the study prospectively to reduce the chances of misclassification bias. The study’s 204	
chief limitations were the relatively low numbers of patients diagnosed with CMV 205	
retinitis and uncertain generalizability outside Thailand.  206	
In conclusion, this prospective cross-sectional analysis showed that ocular 207	
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symptoms and poor visual acuity were poor diagnostic indicators for the presence 208	
of CMV retinitis. Systemic screening for HIV patients with CD4 count below 100 209	
cells/µl should be carried out to catch the disease at its early stage to avoid 210	
blindness.211	
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